Clinical Trial Update: Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating toripalimab combined with axitinib as neoadjuvant therapy for non-metastatic locally advanced clear cell renal cell carcinoma has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Non-metastatic Locally Advanced Renal Cell Carcinoma

Drugs mentioned

• Axitinib (Axitinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: RenJi Hospital | Conditions: Neoadjuvant Therapy of Non-metastatic Locally Advanced Renal Cell Carcinoma | Phase 2 | Status: COMPLETED